Use of the ROSE risk score for predicting mortality and cardiovascular events in adult patients at 7 and 30 days of syncope
Fuente:
Redalyc
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artículo científico |
| Langue: | en |
| Publié: |
Universidad Nacional de Colombia
2016
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1876490117933170688 |
|---|---|
| author | Manuel Agustín Paz-Meneses |
| author_facet | Manuel Agustín Paz-Meneses |
| contents | Use of the ROSE risk score for predicting mortality and cardiovascular events in adult patients at 7 and 30 days of syncope Manuel Agustín Paz-Meneses Guillermo Mora-Pabón Medicina Syncope Cardiovascular Prognosis (MeSH) Introduction: The use of the ROSE risk score after syncope provides the possibility of identifying patients at risk of death or other important adverse events after 30 days of admission to the emergency department. Objective: To evaluate the performance of ROSE score in terms of mortality prediction and major adverse events at 7 and 30 days in adult patients with syncope admitted to the emergency department. Materials and methods: A prospective cohort study in patients with syncope who were admitted to the emergency room was performed. An operational analysis of the predictive ability for detection of possible complications was done by calculating sensitivity, specificity, positive and negative predictive values and ROC curves. Results: 60 patients were evaluated. An area under the curve for prediction of mortality or major outcome at 7 and 30 days of 0.62 (95%CI: 0.45-0.78) was obtained, with sensitivity of 60%, specificity of 18.18%, PPV of 6.25% and NPV of 83%. Conclusion: ROSE score showed low sensitivity for predicting mortality or serious outcomes at 7 and 30 days. Its high negative predictive value makes it a useful prognostic tool in low risk patients. 2016 artículo científico 2357-3848 https://www.redalyc.org/articulo.oa?id=576364352012 https://www.redalyc.org/journal/5763/576364352012/ https://www.redalyc.org/journal/5763/576364352012/html/ https://www.redalyc.org/journal/5763/576364352012/576364352012.epub https://www.redalyc.org/journal/5763/576364352012/movil 10.15446/revfacmed.v64n3.53015 en http://www.redalyc.org/revista.oa?id=5763 Revista de la Facultad de Medicina application/pdf Universidad Nacional de Colombia Revista de la Facultad de Medicina (Colombia) Num.3 Vol.64 |
| format | Artículo científico |
| id | redalyc_576364352012 |
| institution | Redalyc |
| language | en |
| publishDate | 2016 |
| publisher | Universidad Nacional de Colombia |
| spellingShingle | Use of the ROSE risk score for predicting mortality and cardiovascular events in adult patients at 7 and 30 days of syncope Manuel Agustín Paz-Meneses Medicina Syncope Cardiovascular Prognosis (MeSH) Use of the ROSE risk score for predicting mortality and cardiovascular events in adult patients at 7 and 30 days of syncope Manuel Agustín Paz-Meneses Guillermo Mora-Pabón Medicina Syncope Cardiovascular Prognosis (MeSH) Introduction: The use of the ROSE risk score after syncope provides the possibility of identifying patients at risk of death or other important adverse events after 30 days of admission to the emergency department. Objective: To evaluate the performance of ROSE score in terms of mortality prediction and major adverse events at 7 and 30 days in adult patients with syncope admitted to the emergency department. Materials and methods: A prospective cohort study in patients with syncope who were admitted to the emergency room was performed. An operational analysis of the predictive ability for detection of possible complications was done by calculating sensitivity, specificity, positive and negative predictive values and ROC curves. Results: 60 patients were evaluated. An area under the curve for prediction of mortality or major outcome at 7 and 30 days of 0.62 (95%CI: 0.45-0.78) was obtained, with sensitivity of 60%, specificity of 18.18%, PPV of 6.25% and NPV of 83%. Conclusion: ROSE score showed low sensitivity for predicting mortality or serious outcomes at 7 and 30 days. Its high negative predictive value makes it a useful prognostic tool in low risk patients. 2016 artículo científico 2357-3848 https://www.redalyc.org/articulo.oa?id=576364352012 https://www.redalyc.org/journal/5763/576364352012/ https://www.redalyc.org/journal/5763/576364352012/html/ https://www.redalyc.org/journal/5763/576364352012/576364352012.epub https://www.redalyc.org/journal/5763/576364352012/movil 10.15446/revfacmed.v64n3.53015 en http://www.redalyc.org/revista.oa?id=5763 Revista de la Facultad de Medicina application/pdf Universidad Nacional de Colombia Revista de la Facultad de Medicina (Colombia) Num.3 Vol.64 |
| title | Use of the ROSE risk score for predicting mortality and cardiovascular events in adult patients at 7 and 30 days of syncope |
| topic | Medicina Syncope Cardiovascular Prognosis (MeSH) |
| url | https://www.redalyc.org/articulo.oa?id=576364352012 https://www.redalyc.org/journal/5763/576364352012/ https://www.redalyc.org/journal/5763/576364352012/html/ https://www.redalyc.org/journal/5763/576364352012/576364352012.epub https://www.redalyc.org/journal/5763/576364352012/movil |